These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33012876)

  • 21. The efficacy and safety of adjunctive intranasal esketamine treatment in major depressive disorder: a systematic review and meta-analysis.
    Jawad MY; Di Vincenzo JD; Ceban F; Jaberi S; Lui LMW; Gillissie ES; Alnafeesi Y; Rosenblat JD; McIntyre RS
    Expert Opin Drug Saf; 2022 Jun; 21(6):841-852. PubMed ID: 35387538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis.
    Xiong J; Lipsitz O; Chen-Li D; Rosenblat JD; Rodrigues NB; Carvalho I; Lui LMW; Gill H; Narsi F; Mansur RB; Lee Y; McIntyre RS
    J Psychiatr Res; 2021 Feb; 134():57-68. PubMed ID: 33360864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral ketamine for depression: An updated systematic review.
    Meshkat S; Haikazian S; Di Vincenzo JD; Fancy F; Johnson D; Chen-Li D; McIntyre RS; Mansur R; Rosenblat JD
    World J Biol Psychiatry; 2023; 24(7):545-557. PubMed ID: 36651238
    [No Abstract]   [Full Text] [Related]  

  • 24. Efficacy and adverse effects of ketamine versus electroconvulsive therapy for major depressive disorder: A systematic review and meta-analysis.
    de A Simoes Moreira D; Gauer LE; Teixeira G; Fonseca da Silva AC; Cavalcanti S; Quevedo J
    J Affect Disord; 2023 Jun; 330():227-238. PubMed ID: 36907464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy, tolerability, and acceptability of bupropion for major depressive disorder: a meta-analysis of randomized-controlled trials comparison with venlafaxine.
    Maneeton N; Maneeton B; Eurviriyanukul K; Srisurapanont M
    Drug Des Devel Ther; 2013; 7():1053-62. PubMed ID: 24101861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Systematic Review on the Efficacy of Intravenous Racemic Ketamine for Bipolar Depression.
    Joseph B; Parsaik AK; Ahmed AT; Erwin PJ; Singh B
    J Clin Psychopharmacol; 2021 Jan/Feb 01; 41(1):71-75. PubMed ID: 33347027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression.
    Zheng W; Zhou YL; Liu WJ; Wang CY; Zhan YN; Li HQ; Chen LJ; Li MD; Ning YP
    J Psychiatr Res; 2018 Nov; 106():61-68. PubMed ID: 30278319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression: A Randomized Clinical Trial.
    Daly EJ; Singh JB; Fedgchin M; Cooper K; Lim P; Shelton RC; Thase ME; Winokur A; Van Nueten L; Manji H; Drevets WC
    JAMA Psychiatry; 2018 Feb; 75(2):139-148. PubMed ID: 29282469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative effectiveness of continuation and maintenance treatments for persistent depressive disorder in adults.
    Machmutow K; Meister R; Jansen A; Kriston L; Watzke B; Härter MC; Liebherz S
    Cochrane Database Syst Rev; 2019 May; 5(5):CD012855. PubMed ID: 31106850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meta-analysis of short- and mid-term efficacy of ketamine in unipolar and bipolar depression.
    Romeo B; Choucha W; Fossati P; Rotge JY
    Psychiatry Res; 2015 Dec; 230(2):682-8. PubMed ID: 26548981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and tolerability of milnacipran in the treatment of major depression in comparison with other antidepressants : a systematic review and meta-analysis.
    Nakagawa A; Watanabe N; Omori IM; Barbui C; Cipriani A; McGuire H; Churchill R; Furukawa TA;
    CNS Drugs; 2008; 22(7):587-602. PubMed ID: 18547127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Daily oral ketamine for the treatment of depression and anxiety in patients receiving hospice care: a 28-day open-label proof-of-concept trial.
    Irwin SA; Iglewicz A; Nelesen RA; Lo JY; Carr CH; Romero SD; Lloyd LS
    J Palliat Med; 2013 Aug; 16(8):958-65. PubMed ID: 23805864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjunctive intranasal esketamine for major depressive disorder: A systematic review of randomized double-blind controlled-placebo studies.
    Zheng W; Cai DB; Xiang YQ; Zheng W; Jiang WL; Sim K; Ungvari GS; Huang X; Huang XX; Ning YP; Xiang YT
    J Affect Disord; 2020 Mar; 265():63-70. PubMed ID: 31957693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ketamine and depression: a narrative review.
    Corriger A; Pickering G
    Drug Des Devel Ther; 2019; 13():3051-3067. PubMed ID: 31695324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pirlindole in the treatment of depression: a meta-analysis.
    Macedo A; Leiria E; Filipe A
    Clin Drug Investig; 2011; 31(1):61-71. PubMed ID: 21053988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ketamine vs Electroconvulsive Therapy for Major Depressive Episode: A Systematic Review and Meta-analysis.
    Menon V; Varadharajan N; Faheem A; Andrade C
    JAMA Psychiatry; 2023 Jun; 80(6):639-642. PubMed ID: 37043224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study.
    Popova V; Daly EJ; Trivedi M; Cooper K; Lane R; Lim P; Mazzucco C; Hough D; Thase ME; Shelton RC; Molero P; Vieta E; Bajbouj M; Manji H; Drevets WC; Singh JB
    Am J Psychiatry; 2019 Jun; 176(6):428-438. PubMed ID: 31109201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are antipsychotics or antidepressants needed for psychotic depression? A systematic review and meta-analysis of trials comparing antidepressant or antipsychotic monotherapy with combination treatment.
    Farahani A; Correll CU
    J Clin Psychiatry; 2012 Apr; 73(4):486-96. PubMed ID: 22579147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological treatment for psychotic depression.
    Wijkstra J; Lijmer J; Burger H; Geddes J; Nolen WA
    Cochrane Database Syst Rev; 2013 Nov; (11):CD004044. PubMed ID: 24282034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of Ketamine in Bipolar Depression: Systematic Review and Meta-analysis.
    Parsaik AK; Singh B; Khosh-Chashm D; Mascarenhas SS
    J Psychiatr Pract; 2015 Nov; 21(6):427-35. PubMed ID: 26554325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.